Feeling the pressure: a cross-sectional study exploring feasibility of a healthcare Pop-Up for intraocular pressure measurements in shopping centres in England [PDF]
, 2019 OBJECTIVES: To test the hypothesis that a shopping centre Pop-Up health check combining an intraocular pressure (IOP) check with a general health check (blood pressure (BP)) is more readily accepted by the general public than an IOP check only.
Campbell, P. +5 more
core +1 more source
Personalizing Intraocular Pressure
Asia-Pacific Journal of Ophthalmology, 2016 Determining target intraocular pressure (IOP) in glaucoma patients is multifaceted, requiring attention to many different factors such as glaucoma type, severity of disease, age, race, family history, corneal thickness and hysteresis, and initial IOP.
Arthur J, Sit, Christopher M, Pruet
openaire +2 more sources
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
Frontiers in Medicine, 2022 Glaucoma is the leading cause of irreversible blindness worldwide. Several risk factors have been involved in the pathogenesis of the disease. By now, the main treatable risk factor is elevated intraocular pressure.
Alessio Martucci +5 more
doaj +1 more source
Role of advanced technology in the detection of sight-threatening eye disease in a UK community setting. [PDF]
, 2019 Background/aims: To determine the performance of combinations of structural and functional screening tests in detecting sight-threatening eye disease in a cohort of elderly subjects recruited from primary care.
Ctori, I. +6 more
core +1 more source
Target intraocular pressure in the management of glaucoma.
Collegium antropologicum, 2005 Achievement of target intraocular pressure is the goal of every efficient antiglaucoma therapy. Target intraocular pressure is the level of intraocular pressure which is associated with minimal likelihood of visual field or optic nerve lesion, or an existing lesion progression due to elevated intraocular pressure.
Popović-Suić S. +5 more
+8 more sources
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Cells, 2021 Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual information to the brain. Currently, the only available therapies target the lowering of
James R. Tribble +6 more
doaj +1 more source
Magnetic Resonance Imaging of Optic Nerve Traction During Adduction in Primary Open-Angle Glaucoma With Normal Intraocular Pressure. [PDF]
, 2017 PurposeWe used magnetic resonance imaging (MRI) to ascertain effects of optic nerve (ON) traction in adduction, a phenomenon proposed as neuropathic in primary open-angle glaucoma (POAG).MethodsSeventeen patients with POAG and maximal IOP ≤ 20 mm Hg, and
Bonelli, Laura +8 more
core +1 more source
New Therapeutic Targets for Intraocular Pressure Lowering
ISRN Ophthalmology, 2013 Primary open-angle glaucoma (POAG) is a leading cause of irreversible and preventable blindness and ocular hypertension is the strongest known risk factor. With current classes of drugs, management of the disease focuses on lowering intraocular pressure (IOP). Despite of their use to modify the course of the disease, none of the current medications for
Rocha-Sousa, A. +6 more
openaire +2 more sources
Hydrostatic pressure does not cause detectable changes to survival of human retinal ganglion [PDF]
, 2015 Purpose: Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. One consequence of raised IOP is that ocular tissues are subjected to increased hydrostatic pressure (HP).
Amal Aldarwesh +35 more
core +2 more sources
Journal of Ophthalmology, 2021 Background: Until now, no direct relationship has been established between the target pressure and particular corneal thickness for measurements with different types of tonometers.
Dmitriev S. K. +3 more
doaj +1 more source